Lanzamiento Enero 2027

Ensayo controlado aleatorizado2021

The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis: A Randomized, Double-blind, Placebo-controlled Feasibility Study

Dover S, Stephens S, Schneiderman JE, Pullenayegum E, Wells GD, Levy DM, Marcuz JA, Whitney K, Schulze A, Tein I, Feldman BM

The Journal of rheumatology · 14 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Organización sin fines de lucro
Rare Disease Foundation
Organización sin fines de lucro
Myositis Association
Organización sin fines de lucro
Cure JM Foundation
Universidad u hospital
University of Toronto
Gobierno
Canadian Institutes of Health Research

Según 5 financiadores declarados.

Publicación

Publicado
2020-08-01 · J Rheumatol · vol. 48 · número 3 · págs. 434–441
Editorial
The Journal of Rheumatology Publishing Company Limited
Citado
18 citas · más que el 79% de estudios similares · 1.2× el promedio de su campo
Referencias
50 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Inflammatory Myopathies and Dermatomyositis · Muscle metabolism and nutrition · Muscle Physiology and Disorders
Palabras clave
creatine supplementation, juvenile dermatomyositis, muscle function, muscle metabolism, phosphocreatine, muscle pH, cardiorespiratory fitness, fatigue, quality of life, physical activity, research feasibility, medication adherence, safety
MeSH
muscles, muscle, skeletal, humans, myositis, creatine, feasibility studies, double-blind method, quality of life, dietary supplements, child, muscle strength

11 autores

  • Saunya Dover🇬🇧🇨🇦Great Ormond Street Hospital; Hospital for Sick Children
  • Samantha Stephens🇬🇧🇨🇦Great Ormond Street Hospital; Hospital for Sick Children
  • Jane E. Schneiderman🇨🇦University of Toronto; Hospital for Sick Children
  • Eleanor Pullenayegum🇨🇦University of Toronto; Hospital for Sick Children
  • Greg D. Wells🇬🇧🇨🇦Great Ormond Street Hospital; Hospital for Sick Children
  • Deborah M. Levy🇨🇦University of Toronto; Hospital for Sick Children
  • Jo-Anne Marcuz🇬🇧🇨🇦Great Ormond Street Hospital; Hospital for Sick Children
  • Kristi Whitney🇬🇧🇨🇦Great Ormond Street Hospital; Hospital for Sick Children
  • Andreas Schulze🇨🇦Hospital for Sick Children
  • Ingrid Tein🇨🇦University of Toronto; Hospital for Sick Children
  • Brian Michael Feldman🇨🇦University of Toronto; Hospital for Sick Children

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objective

To evaluate the feasibility of studying creatine in juvenile dermatomyositis (JDM). Secondary objectives were to determine the effect of creatine on muscle function and metabolism, aerobic capacity, fatigue, physical activity, and quality of life (QOL), as well as its safety.

Methods

We conducted a 6-month, double-blind, randomized, multiple-baseline design; patients were assigned to creatine or placebo. Feasibility was assessed using attended study visits, completed study procedures, and adherence. Muscle function, aerobic capacity, and muscle strength were assessed with standardized exercise tests. Muscle metabolism was assessed using a 31-Phosphorus Magnetic Resonance Spectroscopy protocol. Fatigue, physical activity, and QOL were assessed by questionnaires. Statistical significance was estimated using a randomization (permutation) test. Changes in outcome measures taken at baseline and end-of-study were calculated using paired t-tests.

Results

Median (range) adherence to the study drug was 88.5% (20.5-95.5%) and the proportion of subjects with 80% adherence or higher was 76.9%. There were no missed study visits. There were no statistically significant changes in muscle function, strength, aerobic capacity, disease activity, fatigue, physical activity, or QOL while subjects were receiving creatine compared to placebo. There were statistically significant adaptations in muscle metabolism (e.g., decrease in change in muscle pH following exercise, and decrease in phosphate/phosphocreatine ratio) at the end-of-study compared to baseline. There were no significant adverse effects.

Conclusion

Creatine supplementation in children with JDM is feasible to study, and is safe and well-tolerated; it may lead to improvements in muscle metabolism.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.